GGrantIndex
← Leaderboards

Marie C Gelato

State University New York Stony Brook

$11,221,556
Attributed
$11,221,556
Total exposure
26
Grants
17
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2M · FY200512
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$11,453,886 · 27

By mechanism

R01$4,890,126 · 2
M01$3,714,789 · 21
K30$2,384,311 · 2
P20$464,660 · 2

Top collaborators

No co-investigators on record.

Most similar at State University New York Stony Brook

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchHuman SubjectHiv InfectionsHuman Therapy EvaluationInstitutionResourcesFundingInsulin Sensitivity /ResistanceResearch PersonnelDiabetes MellitusUnited States National Institutes Of HealthAdipose TissueHyperlipidemiaBody CompositionInsulinSourceMuscleLipodystrophyComputer Retrieval Of Information On Scientific Projects DatabaseGrantAids TherapyMetabolism DisorderClinical TrialsBiometry

Grant awards (49)

Clinical Research Curriculum Award (K30)$290,815
K30 · FY2012 · TR · contact PI
Clinical Research Curriculum Award (K30)$293,496
K30 · FY2011 · RR · contact PI
Clinical Research Curriculum Award (K30)$300,000
K30 · FY2010 · RR · contact PI
CLINICAL TRIAL: A NOVEL THERAPY FOR GLUCOSE INTOLERANCE IN HIV DISEASE$632,138
M01 · FY2009 · RR · contact PI
Clinical Research Training Program$300,000
K30 · FY2009 · RR · contact PI
MECHANISMS OF SUBCUTANEOUS FAT LOSS IN AGING AND HIV DISEASE$34,638
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: A NOVEL THERAPY FOR GLUCOSE INTOLERANCE IN HIV DISEASE$884,949
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: PPAR MEDICATED GENE EXPRESSION IN HIV PATIENTS$489,546
M01 · FY2008 · RR · contact PI
Novel Therapy for Glucose Intolerance in HIV Disease$348,575
R01 · FY2008 · AT · contact PI
Clinical Research Training Program$300,000
K30 · FY2008 · RR · contact PI
CLINICAL TRIAL: CELLULAR MECHANISMS FOR SARCOPENIA IN THE ELDERLY$2,612
M01 · FY2008 · RR · contact PI
PPAR MEDICATED GENE EXPRESSION IN HIV PATIENTS$695,754
M01 · FY2007 · RR · contact PI
PPAR Mediated Gene Expression in HIV Patients$521,806
R01 · FY2007 · DK · contact PI
Novel Therapy for Glucose Intolerance in HIV Disease$355,688
R01 · FY2007 · AT · contact PI
Clinical Research Training Program$300,000
K30 · FY2007 · RR · contact PI
A NOVEL THERAPY FOR GLUCOSE INTOLERANCE IN HIV DISEASE$121,699
M01 · FY2007 · RR · contact PI
CELLULAR MECHANISMS FOR SARCOPENIA IN THE ELDERLY$31,380
M01 · FY2007 · RR · contact PI
PPAR Mediated Gene Expression in HIV Patients$526,992
R01 · FY2006 · DK · contact PI
Novel Therapy for Glucose Intolerance in HIV Disease$352,246
R01 · FY2006 · AT · contact PI
Clinical Research Training Program$300,000
K30 · FY2006 · RR · contact PI
CTSA Planning Grant$232,330
P20 · FY2006 · RR · contact PI
CTSA PLANNING GRANT$232,330
P20 · FY2006 · RR · contact PI
CELLULAR MECHANISMS FOR SARCOPENIA IN THE ELDERLY$166,416
M01 · FY2006 · RR · contact PI
PPAR MEDICATED GENE EXPRESSION IN HIV PATIENTS$136,895
M01 · FY2006 · RR · contact PI
MECHANISMS OF CHROMIUM'S EFFECT ON INSULIN SENSITIVITY$7,853
M01 · FY2006 · RR · contact PI
CHROMIUM TREATMENT OF HIV-RELATED INSULIN RESISTANCE$2,247
M01 · FY2006 · RR · contact PI
PPAR Mediated Gene Expression in HIV Patients$528,390
R01 · FY2005 · DK
Novel Therapy for Glucose Intolerance in HIV Disease$357,200
R01 · FY2005 · AT
Clinical Research Training Program$300,000
K30 · FY2005 · RR
CELLULAR MECHANISMS FOR SARCOPENIA IN THE ELDERLY$92,420
M01 · FY2005 · RR
MECHANISMS OF CHROMIUM'S EFFECT ON INSULIN SENSITIVITY$54,770
M01 · FY2005 · RR
PPAR Mediated Gene Expression in HIV Patients$45,600
R01 · FY2005 · DK
ULTRASOUND ASSESSMENT OF PREDISPOSITION FOR VASCULAR DISEASE$371
M01 · FY2005 · RR
PPAR Mediated Gene Expression in HIV Patients$524,962
R01 · FY2004 · DK
Cellular Mechanisms for Sarcopenia in the Elderly$81,331
M01 · FY2004 · RR
Mechanisms of Chromium's Effect on Insulin Sensitivity$72,340
M01 · FY2004 · RR
Cellular Mechanisms of Metabolic Dysfunction in HIV Disease$17,645
M01 · FY2004 · RR
Altered Insulin Sensitivity with GH Treatment$16,761
M01 · FY2004 · RR
Use of Topical Steroid Ointment to Treat Nasal Allergy$15,814
M01 · FY2004 · RR
ULTRASOUND ASSESSMENT OF PREDISPOSITION FOR VASCULAR DISEASE$376
M01 · FY2004 · RR
CELLULAR MECHANISMS FOR METABOLIC DYSFUNCTION IN HIV$449,443
R01 · FY2002 · DK
CELLULAR MECHANISMS FOR METABOLIC DYSFUNCTION IN HIV$442,825
R01 · FY2001 · DK
Cellular Mechanisms of Metabolic Dysfunction in HIV Disease$0
M01 · FY2001 · RR
Altered insulin sensitivity with GH treatment$0
M01 · FY2001 · RR
MUSCLE PROTEIN SYNTHESIS AND GH/IGF AXIS IN AIDS$0
M01 · FY2001 · RR
CELLULAR MECHANISMS FOR METABOLIC DYSFUNCTION IN HIV$436,399
R01 · FY2000 · DK
Altered insulin sensitivity with GH treatment$78,419
M01 · FY2000 · RR
MUSCLE PROTEIN SYNTHESIS AND GH/IGF AXIS IN AIDS$78,415
M01 · FY2000 · RR
Cellular Mechanisms of Metabolic Dysfunction in HIV Disease$0
M01 · FY2000 · RR